社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
晶泰控股(02228)
12.640
+0.170
+1.36%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
骏马飞驰吧
·
01-16 12:10
$晶泰控股(02228)$
生物科技投资高风险高回报，AI制药可阶段性低位布局
$晶泰控股(02228)$ 生物科技投资高风险高回报，AI制药可阶段性低位布局
回复
评论
点赞
1
编组 21备份 2
分享
举报
流入决定股价
·
01-15 12:20
$晶泰控股(02228)$
中邮证券发布研报称，2026年初政策支持与海外AI医疗公司高增长表现，共同催化“AI+医疗”产业机遇。据预测，2030年全球市场规模有望达1553亿美元，中国将快速增长至168亿美元。
$晶泰控股(02228)$ 中邮证券发布研报称，2026年初政策支持与海外AI医疗公司高增长表现，共同催化“AI+医疗”产业机遇。据预测，2030年全球市...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
流入决定股价
·
01-14 11:32
$晶泰控股(02228)$
开始发力拉升，晶泰今天要量价齐飞
$晶泰控股(02228)$ 开始发力拉升，晶泰今天要量价齐飞
回复
评论
点赞
1
编组 21备份 2
分享
举报
电白小白15
·
01-14 15:53
$晶泰控股(02228)$
晶泰因具备真实实验验证能力，被多数专业投资者视为“非泡沫型AI药企”，值得长期投资
$晶泰控股(02228)$ 晶泰因具备真实实验验证能力，被多数专业投资者视为“非泡沫型AI药企”，值得长期投资
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
G股叶荣添
·
01-13
$晶泰控股(02228)$
晶泰控股所代表的“AI+研发”模式，理论上能够参与这一广阔市场的价值重构，且当前竞争格局尚未固化，为头部技术公司提供了绝佳的时间窗口
$晶泰控股(02228)$ 晶泰控股所代表的“AI+研发”模式，理论上能够参与这一广阔市场的价值重构，且当前竞争格局尚未固化，为头部技术公司提供了绝佳的时间窗口
回复
评论
点赞
1
编组 21备份 2
分享
举报
莎士比亚的微笑
·
01-12
$晶泰控股(02228)$
晶泰拟发行28.66亿港元零息可转换债券，初始转换价13.85港元，较当日收盘价11.54港元溢价约20%，募集资金将用于提升国内外研发能力、商业化团队扩张及产能建设
$晶泰控股(02228)$ 晶泰拟发行28.66亿港元零息可转换债券，初始转换价13.85港元，较当日收盘价11.54港元溢价约20%，募集资金将用于提升...
回复
评论
点赞
1
编组 21备份 2
分享
举报
老肥121
·
01-12
$晶泰控股(02228)$
$晶泰控股(02228)$
# 晒晒更赚钱
回复
评论
点赞
1
编组 21备份 2
分享
举报
股市时光机
·
01-12
$晶泰控股(02228)$
股价要起飞了，晶泰估值要回暖
$晶泰控股(02228)$ 股价要起飞了，晶泰估值要回暖
回复
评论
点赞
1
编组 21备份 2
分享
举报
明大教主
·
01-13
创新药去年的行情是由大规模的BD驱动。投资者可见国内创新药企授权海外的总金额、首付款、项目数都是历史新高，叠加有政策鼓励保险及其他机构长期投资，从而引发一窝蜂行情。 但从最近几个月创新药板块的回撤可见，国内机构仍过于看重创新药“短期盈利”，对于创新药如此高风险+高回报的标的，估值宽容度比美国那边还差了很远。创新药进入了筛选标的而非无脑投资指数的阶段。 不过大伙也不用太担心，去年创新药公司融资+BD回笼现金流规模相当可观，未来3年不会陷入2022年后盈利与现金流的两难境地，想要在2024年估值相当位置捡便宜的投资者可能要失望。 值得注意的是AI之风炒到了医药、医疗上来，除了
$晶泰控股(02228)$
、
$英矽智能(03696)$
这几个正宗的，A股那些几乎全是无法兑现业绩的纯概念股，投资者还要多一份谨慎！且炒且珍惜！
创新药去年的行情是由大规模的BD驱动。投资者可见国内创新药企授权海外的总金额、首付款、项目数都是历史新高，叠加有政策鼓励保险及其他机构长期投资，从而引发一...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Larri
·
01-09
$晶泰控股(02228)$
老朋友，终于反转了
$晶泰控股(02228)$ 老朋友，终于反转了
# 晒晒更赚钱
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
晶泰控股
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
https://www.xtalpi.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。
01-08
股份发行
建议发行2,866,000,000港元于2027年到期的零息可转换债券
建议发行2,866,000,000港元于2027年到期的零息可转换债券
2025-09-16
半年度报告
2025中期报告
2025中期报告
2025-09-16
半年度报告
有关截至2025年6月30日止六个月的中期业绩公告的澄清公告
有关截至2025年6月30日止六个月的中期业绩公告的澄清公告
2025-09-04
股份发行
完成根据一般授权配售新股份
完成根据一般授权配售新股份
2025-08-29
股份发行
根据一般授权配售新股份
根据一般授权配售新股份
2025-08-27
半年度报告
截至2025年6月30日止六个月的中期业绩公告
截至2025年6月30日止六个月的中期业绩公告
2025-08-12
业绩预告
正面盈利预告
正面盈利预告
2025-05-11
须予披露的交易
有关收购目标公司90%股权之须予披露交易
有关收购目标公司90%股权之须予披露交易
2025-04-07
股份购回
建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告
建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告
2025-04-07
年度报告
2024年度报告
2024年度报告
2025-03-28
年度报告
截至2024年12月31日止年度的年度业绩公告
截至2024年12月31日止年度的年度业绩公告
2025-02-19
股份发行
根据一般授权配售新股份
根据一般授权配售新股份
2025-01-24
股份发行
完成根据一般授权配售新股份
完成根据一般授权配售新股份
2025-01-19
股份发行
根据一般授权配售新股份
根据一般授权配售新股份
2024-09-16
半年度报告
2024中期报告
2024中期报告
分时
5日
日
周
月
数据加载中...
最高
12.960
今开
12.690
量比
0.42
最低
12.400
昨收
12.470
换手率
2.13%
热议股票
{"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"02228","data":{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":12.64,"timestamp":1768550905004,"preClose":12.47,"halted":0,"volume":91475454,"delay":0,"changeRate":0.013632718524458694,"floatShares":4303000000,"shares":4303000000,"eps":-0.786038,"marketStatus":"休市中","change":0.17,"latestTime":"01-16 16:08:25","open":12.69,"high":12.96,"low":12.4,"amount":1158719133,"amplitude":0.044908,"askPrice":12.65,"askSize":172000,"bidPrice":12.64,"bidSize":295000,"shortable":3,"etf":0,"ttmEps":-0.05,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768786200000},"marketStatusCode":7,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":12.47,"openAndCloseTimeList":[[1768527000000,1768536000000],[1768539600000,1768550400000]],"volumeRatio":0.418823,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.522242320303536","cardData":[{"tweetId":"522242320303536","author":{"authorId":"4184380269673420","idStr":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 生物科技投资高风险高回报，AI制药可阶段性低位布局","plainDigest":"$晶泰控股(02228)$ 生物科技投资高风险高回报，AI制药可阶段性低位布局","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768536601786,"gmtModify":1768536603865,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":71,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/522242320303536","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":64,"displayRows":4,"foldSize":0,"authorId":"4184380269673420"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.521891032700456","cardData":[{"tweetId":"521891032700456","author":{"authorId":"3528693420770894","idStr":"3528693420770894","name":"流入决定股价","avatar":"https://static.tigerbbs.com/93e31ab9c41448c89e97218f249287ef","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 中邮证券发布研报称，2026年初政策支持与海外AI医疗公司高增长表现，共同催化“AI+医疗”产业机遇。据预测，2030年全球市场规模有望达1553亿美元，中国将快速增长至168亿美元。","plainDigest":"$晶泰控股(02228)$ 中邮证券发布研报称，2026年初政策支持与海外AI医疗公司高增长表现，共同催化“AI+医疗”产业机遇。据预测，2030年全球市场规模有望达1553亿美元，中国将快速增长至168亿美元。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768450847015,"gmtModify":1768450850441,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":303,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/521891032700456","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":173,"displayRows":4,"foldSize":0,"authorId":"3528693420770894"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.521509374083576","cardData":[{"tweetId":"521509374083576","author":{"authorId":"3528693420770894","idStr":"3528693420770894","name":"流入决定股价","avatar":"https://static.tigerbbs.com/93e31ab9c41448c89e97218f249287ef","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 开始发力拉升，晶泰今天要量价齐飞","plainDigest":"$晶泰控股(02228)$ 开始发力拉升，晶泰今天要量价齐飞","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768361531055,"gmtModify":1768361532939,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":134,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/521509374083576","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":48,"displayRows":4,"foldSize":0,"authorId":"3528693420770894"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.521666709491800","cardData":[{"tweetId":"521666709491800","author":{"authorId":"4218363023229180","idStr":"4218363023229180","name":"电白小白15","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰因具备真实实验验证能力，被多数专业投资者视为“非泡沫型AI药企”，值得长期投资","plainDigest":"$晶泰控股(02228)$ 晶泰因具备真实实验验证能力，被多数专业投资者视为“非泡沫型AI药企”，值得长期投资","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768377198306,"gmtModify":1768377201648,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":119,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/521666709491800","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":93,"displayRows":4,"foldSize":0,"authorId":"4218363023229180"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.521305870317000","cardData":[{"tweetId":"521305870317000","author":{"authorId":"4218001298160580","idStr":"4218001298160580","name":"G股叶荣添","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰控股所代表的“AI+研发”模式，理论上能够参与这一广阔市场的价值重构，且当前竞争格局尚未固化，为头部技术公司提供了绝佳的时间窗口","plainDigest":"$晶泰控股(02228)$ 晶泰控股所代表的“AI+研发”模式，理论上能够参与这一广阔市场的价值重构，且当前竞争格局尚未固化，为头部技术公司提供了绝佳的时间窗口","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768306879737,"gmtModify":1768306881569,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":491,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/521305870317000","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":141,"displayRows":4,"foldSize":0,"authorId":"4218001298160580"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.521110180676272","cardData":[{"tweetId":"521110180676272","author":{"authorId":"4218427800237090","idStr":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰拟发行28.66亿港元零息可转换债券，初始转换价13.85港元，较当日收盘价11.54港元溢价约20%，募集资金将用于提升国内外研发能力、商业化团队扩张及产能建设","plainDigest":"$晶泰控股(02228)$ 晶泰拟发行28.66亿港元零息可转换债券，初始转换价13.85港元，较当日收盘价11.54港元溢价约20%，募集资金将用于提升国内外研发能力、商业化团队扩张及产能建设","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768207753128,"gmtModify":1768208668795,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":221,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/521110180676272","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":161,"displayRows":4,"foldSize":0,"authorId":"4218427800237090"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.520937540641064","cardData":[{"tweetId":"520937540641064","author":{"authorId":"3487838570195535","idStr":"3487838570195535","name":"老肥121","avatar":"https://static.tigerbbs.com/628636281293a74f4152d31e7ba5a9c4","userType":1,"introduction":"","crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$</a> ","plainDigest":"$晶泰控股(02228)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768203271080,"gmtModify":1768203284234,"symbols":["02228"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/a563547fbf3128fd3d1560c561e5c308","width":"1008","height":"1657"}],"repostCount":0,"viewCount":210,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/520937540641064","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":17,"displayRows":4,"foldSize":0,"authorId":"3487838570195535"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.521078142214744","cardData":[{"tweetId":"521078142214744","author":{"authorId":"4108085372061810","idStr":"4108085372061810","name":"股市时光机","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 股价要起飞了，晶泰估值要回暖","plainDigest":"$晶泰控股(02228)$ 股价要起飞了，晶泰估值要回暖","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768199333678,"gmtModify":1768199335368,"symbols":["02228"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":74,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/521078142214744","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":44,"displayRows":4,"foldSize":0,"authorId":"4108085372061810"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.521366799803040","cardData":[{"tweetId":"521366799803040","author":{"authorId":"4120462527107840","idStr":"4120462527107840","name":"明大教主","avatar":"https://static.tigerbbs.com/7923b570045ef396e894082089df0a6c","userType":2,"introduction":"长期跟踪A、港美股，擅长结合基本面、技术面深度分析","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.14","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":12954,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"创新药去年的行情是由大规模的BD驱动。投资者可见国内创新药企授权海外的总金额、首付款、项目数都是历史新高，叠加有政策鼓励保险及其他机构长期投资，从而引发一窝蜂行情。 但从最近几个月创新药板块的回撤可见，国内机构仍过于看重创新药“短期盈利”，对于创新药如此高风险+高回报的标的，估值宽容度比美国那边还差了很远。创新药进入了筛选标的而非无脑投资指数的阶段。 不过大伙也不用太担心，去年创新药公司融资+BD回笼现金流规模相当可观，未来3年不会陷入2022年后盈利与现金流的两难境地，想要在2024年估值相当位置捡便宜的投资者可能要失望。 值得注意的是AI之风炒到了医药、医疗上来，除了 <a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$</a> 、 <a href=\"https://laohu8.com/S/03696\">$英矽智能(03696)$</a> 这几个正宗的，A股那些几乎全是无法兑现业绩的纯概念股，投资者还要多一份谨慎！且炒且珍惜！","plainDigest":"创新药去年的行情是由大规模的BD驱动。投资者可见国内创新药企授权海外的总金额、首付款、项目数都是历史新高，叠加有政策鼓励保险及其他机构长期投资，从而引发一窝蜂行情。 但从最近几个月创新药板块的回撤可见，国内机构仍过于看重创新药“短期盈利”，对于创新药如此高风险+高回报的标的，估值宽容度比美国那边还差了很远。创新药进入了筛选标的而非无脑投资指数的阶段。 不过大伙也不用太担心，去年创新药公司融资+BD回笼现金流规模相当可观，未来3年不会陷入2022年后盈利与现金流的两难境地，想要在2024年估值相当位置捡便宜的投资者可能要失望。 值得注意的是AI之风炒到了医药、医疗上来，除了 $晶泰控股(02228)$ 、 $英矽智能(03696)$ 这几个正宗的，A股那些几乎全是无法兑现业绩的纯概念股，投资者还要多一份谨慎！且炒且珍惜！","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1768269699744,"gmtModify":1768270974107,"symbols":["02228","03696"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":584,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/521366799803040","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":654,"displayRows":4,"foldSize":0,"authorId":"4120462527107840"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.520030409765576","cardData":[{"tweetId":"520030409765576","author":{"authorId":"3546302369390375","idStr":"3546302369390375","name":"Larri","avatar":"https://static.tigerbbs.com/579061d995087ebabca8fb326cd4996d","userType":1,"introduction":"","crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":27,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 老朋友，终于反转了","plainDigest":"$晶泰控股(02228)$ 老朋友，终于反转了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1767944509023,"gmtModify":1767944521298,"symbols":["02228"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/e2016032f8285a9169cfd44b3281d602","width":"1002","height":"1808"}],"repostCount":0,"viewCount":242,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/520030409765576","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":34,"displayRows":4,"foldSize":0,"authorId":"3546302369390375"}],"position":0}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"20613566","market":"hk","labels":[],"media":"港交所","original_id":"N.HKpFZCS5oMAD","pdf_url":"https://static.tigerbbs.com/d6ba8be361e145fa89bb24fe3209cc6a","pub_time":1767826200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议发行2,866,000,000港元于2027年到期的零息可转换债券","symbol":"02228","title":"建议发行2,866,000,000港元于2027年到期的零息可转换债券","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0108/2026010800042_c.pdf","us_notice_code":"公告及通告 - [发行可转换证券 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2026-01-08 06:50","pubTimestamp":1767826200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20173334","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2NG2aVqHUH","pdf_url":"https://static.tigerbbs.com/81513848524a4cff837ccefaeddc7c75","pub_time":1758017340000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025中期报告","symbol":"02228","title":"2025中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0916/2025091600967_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-16 18:09","pubTimestamp":1758017340,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20173157","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9CcnPXRvWr","pdf_url":"https://static.tigerbbs.com/464bf940313f4110b5256b74bb451a75","pub_time":1758015480000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关截至2025年6月30日止六个月的中期业绩公告的澄清公告","symbol":"02228","title":"有关截至2025年6月30日止六个月的中期业绩公告的澄清公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0916/2025091600877_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-16 17:38","pubTimestamp":1758015480,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20127960","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5uPwhddh4N","pdf_url":"https://static.tigerbbs.com/0ed7f5f3197248879b2ce690495f6532","pub_time":1756978200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股份","symbol":"02228","title":"完成根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0904/2025090401265_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-09-04 17:30","pubTimestamp":1756978200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20097849","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHz6WwQom6t","pdf_url":"https://static.tigerbbs.com/1d463f3b4c3048008f5b11e85aa65bd1","pub_time":1756426560000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股份","symbol":"02228","title":"根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082900312_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-08-29 08:16","pubTimestamp":1756426560,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20068769","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8wg8kqwQGB","pdf_url":"https://static.tigerbbs.com/b22ada1d864c42d594b4ff0fffc892cd","pub_time":1756289400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月的中期业绩公告","symbol":"02228","title":"截至2025年6月30日止六个月的中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082701124_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-27 18:10","pubTimestamp":1756289400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19973118","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2EiNd9dsQV","pdf_url":"https://static.tigerbbs.com/ad28295d8114435c95c09364a773b8bb","pub_time":1754949960000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告","symbol":"02228","title":"正面盈利预告","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0812/2025081200010_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2025-08-12 06:06","pubTimestamp":1754949960,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19626106","market":"hk","labels":[],"media":"港交所","original_id":"N.HK27zCzSG9a4","pdf_url":"https://static.tigerbbs.com/fac64624a5bd419b91583d0552740168","pub_time":1746957900000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关收购目标公司90%股权之须予披露交易","symbol":"02228","title":"有关收购目标公司90%股权之须予披露交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0511/2025051100004_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2025-05-11 18:05","pubTimestamp":1746957900,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19356689","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGfVm67qcMV","pdf_url":"https://static.tigerbbs.com/664ac2d91e4c4411b9354c87cea0e1a7","pub_time":1744027920000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告","symbol":"02228","title":"建议授出一般授权以发行股份及购回股份、重新委任核数师、重选董事及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0407/2025040702158_c.pdf","us_notice_code":"通函 - [一般性授权 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-04-07 20:12","pubTimestamp":1744027920,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19356566","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6dbr3AVfgG","pdf_url":"https://static.tigerbbs.com/5cb4a975ab424720844de70d5000f5cf","pub_time":1744027380000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年度报告","symbol":"02228","title":"2024年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0407/2025040702144_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报 / 环境、社会及管治资料/报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-07 20:03","pubTimestamp":1744027380,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19303855","market":"hk","labels":[],"media":"港交所","original_id":"N.HKDCpCpcFF46","pdf_url":"https://static.tigerbbs.com/978c1d2154b14dbbaddbf449a58b3762","pub_time":1743155820000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年12月31日止年度的年度业绩公告","symbol":"02228","title":"截至2024年12月31日止年度的年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0328/2025032801326_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-28 17:57","pubTimestamp":1743155820,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19113748","market":"hk","labels":[],"media":"港交所","original_id":"N.HK4j79uSacn4","pdf_url":"https://static.tigerbbs.com/2f3a5a9990b14b6dae1a50a72b0df5ec","pub_time":1739921820000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股份","symbol":"02228","title":"根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0219/2025021900054_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-02-19 07:37","pubTimestamp":1739921820,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19072979","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8fDD1jSvSZ","pdf_url":"https://static.tigerbbs.com/c3b31086960d46ec964d03aca43312d9","pub_time":1737710460000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股份","symbol":"02228","title":"完成根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0124/2025012400891_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-01-24 17:21","pubTimestamp":1737710460,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19055383","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCJVuaHN7Mw","pdf_url":"https://static.tigerbbs.com/d482cec62f3d426c8993fe1f8d74c145","pub_time":1737281220000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股份","symbol":"02228","title":"根据一般授权配售新股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0119/2025011900010_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-01-19 18:07","pubTimestamp":1737281220,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18616327","market":"hk","labels":[],"media":"港交所","original_id":"N.HKF6DgZSTkRD","pdf_url":"https://static.tigerbbs.com/6788b962df0b48aaa6620239ae9f6f56","pub_time":1726476840000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024中期报告","symbol":"02228","title":"2024中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0916/2024091600502_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-09-16 16:54","pubTimestamp":1726476840,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":0.365},{"period":"3month","weight":0.1286},{"period":"6month","weight":1.0755},{"period":"1year","weight":1.6837},{"period":"ytd","weight":0.3362}],"compareEarnings":[{"period":"1week","weight":0.0234},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0633},{"period":"6month","weight":0.0813},{"period":"1year","weight":0.3751},{"period":"ytd","weight":0.0474}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"aProfile":null}}}